DeepMed Research

HACKENSACK MERIDIAN HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2016-01-01

Employees: -

Market Cap: -

Website: https://www.hackensackmeridianhealth.org/

Clinical Trials

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Early Phase 1

Recruiting

Conditions: Urinary Retention

Interventions: Drug: Tamsulosin

First Posted Date: 2022-12-20

Last Posted Date: 2025-04-22

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 46

Registration Number: NCT05657990

Locations: 🇺🇸
Ocean University Medical Center, Brick, New Jersey, United States
🇺🇸
South Ocean University Medical Center, Manahawkin, New Jersey, United States
🇺🇸
Jersey Shore University Medical Center, Neptune, New Jersey, United States

and more 5 locations

Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

Not Applicable

Recruiting

Conditions: Stroke
Cerebrovascular Accident

Interventions: Other: Cardiac rehabilitation program

First Posted Date: 2022-12-15

Last Posted Date: 2025-04-22

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 150

Registration Number: NCT05651945

Locations: 🇺🇸
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute, Edison, New Jersey, United States

Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.

Phase 1

Withdrawn

Conditions: Multiple Myeloma, Refractory

Interventions: Drug: Pembrolizumab
Drug: Belantamab mafodotin
Drug: Dexamethasone

First Posted Date: 2022-08-09

Last Posted Date: 2023-01-27

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT05493618

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
Jersey Shore Medical Center, Neptune, New Jersey, United States
🇺🇸
John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, United States

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Carfilzomib
Drug: Iberdomide
Drug: Oral Dexamethasone

First Posted Date: 2022-01-20

Last Posted Date: 2025-05-21

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 66

Registration Number: NCT05199311

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center, Hackensack, New Jersey, United States

Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

Phase 1

Terminated

Conditions: COVID-19

Interventions: Drug: Omega-3 (EPA+DHA)
Drug: Placebo

First Posted Date: 2021-11-16

Last Posted Date: 2024-03-12

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 32

Registration Number: NCT05121766

Locations: 🇺🇸
Susan Dara, Edison, New Jersey, United States

Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study

Early Phase 1

Terminated

Conditions: Dyspnea
COVID-19
Tachycardia

Interventions: Drug: Metoprolol Succinate

First Posted Date: 2021-10-27

Last Posted Date: 2024-12-03

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 14

Registration Number: NCT05096884

Locations: 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States

Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope

Not Applicable

Withdrawn

Conditions: Neurogenic Orthostatic Hypotension

Interventions: Device: Placebo
Device: Sinosuidal Galvanic Vestibular Stimulation

First Posted Date: 2021-07-26

Last Posted Date: 2022-12-16

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT04976101

Locations: 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States

Pain Control Without Opioids

Phase 3

Withdrawn

Conditions: Perioperative Pain

Interventions: Drug: Ibuprofen 600 mg
Drug: OxyCODONE 5 Mg Oral Capsule

First Posted Date: 2021-03-24

Last Posted Date: 2022-09-10

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT04813991

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

Recruiting

Conditions: Embryonal Tumor With Multilayered Rosettes

First Posted Date: 2021-03-12

Last Posted Date: 2024-11-14

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 100

Registration Number: NCT04794686

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome

Early Phase 1

Completed

Conditions: Post-Concussion Syndrome
Headache

Interventions: Other: Osteopathic Manipulative Therapy

First Posted Date: 2021-02-01

Last Posted Date: 2021-05-25

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 26

Registration Number: NCT04732338

Locations: 🇺🇸
Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy